View Exam | PowerPak

1. Which of the following strategies should be incorporated when speaking with patients about influenza therapies and prevention?

A. Use of close-ended questions B. Inclusion of personal bias C. Use of judgmental tone D. Use of empathetic responses E. Unsure

2. When screening for appropriateness of influenza testing, what patient-reported symptom is likely to distinguish influenza from a SARS-CoV-2 infection (COVID-19)?

A. Fever or chills B. Muscle pain or body aches C. Change in or loss of taste or smell D. Shortness of breath or difficulty breathing E. Unsure

3. Which of the following groups has achieved the largest reduction in antibiotic use owing to increasing the influenza vaccination rate by 10%?

A. Adults (19–64 years old) B. Children (≤18 years old) C. Patients infected with C. difficile D. Elderly (≥65 years old) E. Unsure

4. Which of the following statements is TRUE regarding clinical trial information for baloxavir marboxil?

A. It has only been studied for the treatment of influenza type A infection B. It has only been compared for efficacy versus placebo C. It has been compared to oseltamivir for treatment of laboratory-confirmed influenza D. It has not been studied as a preventative measure for contacts of people with influenza E. Unsure

5. Use the following CASE to answer questions 5 & 6:
A 40-year-old female presents to urgent care with a 1-day history of fever, cough, and muscle aches. She denies any known contact for either influenza or SARS-CoV-2 and also states that she has not experienced any alteration in her taste or smell. She also has diabetes (treated with metformin) and asthma (treated with fluticasone).

Which of the following statements is TRUE regarding testing for this patient?

A. She should be tested for seasonal influenza B. She should be tested for COVID-19 C. She should be tested for both influenza and COVID-19 D. She should not be tested for either viral infection E. Unsure

Maintenance is scheduled for 8/7/2023 7:00 AM EST - 8:00 AM EST.

{{recommendationsA.Title}}

{{recommendationsB.Title}}

1. Which of the following strategies should be incorporated when speaking with patients about influenza therapies and prevention?

2. When screening for appropriateness of influenza testing, what patient-reported symptom is likely to distinguish influenza from a SARS-CoV-2 infection (COVID-19)?

3. Which of the following groups has achieved the largest reduction in antibiotic use owing to increasing the influenza vaccination rate by 10%?

4. Which of the following statements is TRUE regarding clinical trial information for baloxavir marboxil?

6. If the patient has influenza type A confirmed by testing, which of the following therapies can be recommended based on convenience and efficacy?

Evaluation Questions

7. How confident are in your testing choice for the 40 year old patient above?

« Return to Activity

Maintenance is scheduled for 8/7/2023 7:00 AM EST - 8:00 AM EST.

The shopping cart is empty

Customers who Purchasedthis Activity also Purchased

{{recommendationsA.Title}}

{{recommendationsB.Title}}

1. Which of the following strategies should be incorporated when speaking with patients about influenza therapies and prevention?

2. When screening for appropriateness of influenza testing, what patient-reported symptom is likely to distinguish influenza from a SARS-CoV-2 infection (COVID-19)?

3. Which of the following groups has achieved the largest reduction in antibiotic use owing to increasing the influenza vaccination rate by 10%?

4. Which of the following statements is TRUE regarding clinical trial information for baloxavir marboxil?

6. If the patient has influenza type A confirmed by testing, which of the following therapies can be recommended based on convenience and efficacy?

Evaluation Questions

7. How confident are in your testing choice for the 40 year old patient above?

« Return to Activity

Customers who Purchased
this Activity also Purchased